Newly created position will scale the growth of Beacon's breakthrough technology to understand brain activity, and help accelerate the development of new treatment approaches
Beacon Biosignals,...
The new no-code protocol library and AI-powered protocol generation tools will empower scientists with automated, easy-to-use workflows for genomics, proteomics, cell biology, and synthetic...
Vivodyne, a biotech that accelerates the successful discovery, design, and development of human therapeutics, announced the appointment of Elliot Menschik, M.D., Ph.D., to the...
DIA, a global organization of life science professionals, and the Tufts Center for the Study of Drug Development (Tufts CSDD) have come together to conduct...
C3 AI, the Enterprise AI application software company, announced that Genentech, the medical biotechnology company, has selected C3 AI Reliability as the continued provider for...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced the formation of TenAces...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and...